ACXP - Acurx Pharmaceuticals Inc. (ACXP) Q4 2023 Earnings Call Transcript
2024-03-18 11:19:09 ET
Acurx Pharmaceuticals, Inc. (ACXP)
Q4 2023 Earnings Conference Call
March 18, 2024 08:00 AM ET
Company Participants
Robert Shawah - CFO
David Luci - President and CEO
Robert DeLuccia - Executive Chairman
Conference Call Participants
Michael Okunewithch - Maxim Group
James Molloy - Alliance Global Partners
Ed Arce - H.C. Wainwright
Presentation
Operator
Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and Business Update Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the call over to your host, Robert Shawah, Chief Financial Officer for Acurx Pharmaceuticals. Thank you. You may begin.
Robert Shawah
Thank you, Melissa. Good morning, and welcome to our call. This morning we issued a press release providing financial results and company highlights for the fourth quarter and full year 2023, which is available on our website at acurxpharma.com. ...
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript